See more : GeneLink, Inc. (GNLKQ) Income Statement Analysis – Financial Results
Complete financial analysis of HealthEquity, Inc. (HQY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HealthEquity, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Sunway International Holdings Limited (0058.HK) Income Statement Analysis – Financial Results
- TowneBank (TOWN) Income Statement Analysis – Financial Results
- Great Novel Therapeutics Biotech & Medicals (7427.TWO) Income Statement Analysis – Financial Results
- Ultimate Sports Entertainment, Inc. (ULSP) Income Statement Analysis – Financial Results
- Frontage Holdings Corporation (FGHQF) Income Statement Analysis – Financial Results
HealthEquity, Inc. (HQY)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.healthequity.com
About HealthEquity, Inc.
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 999.59M | 861.75M | 756.56M | 733.57M | 531.99M | 287.24M | 229.53M | 178.37M | 126.79M | 87.86M | 62.02M | 46.09M |
| Cost of Revenue | 376.95M | 371.66M | 332.85M | 318.24M | 206.08M | 106.05M | 94.61M | 72.02M | 54.19M | 39.88M | 29.21M | 21.97M |
| Gross Profit | 622.64M | 490.09M | 423.71M | 415.33M | 325.91M | 181.19M | 134.92M | 106.36M | 72.60M | 47.97M | 32.80M | 24.12M |
| Gross Profit Ratio | 62.29% | 56.87% | 56.00% | 56.62% | 61.26% | 63.08% | 58.78% | 59.63% | 57.26% | 54.60% | 52.89% | 52.33% |
| Research & Development | 218.81M | 193.38M | 157.36M | 124.81M | 77.58M | 35.06M | 27.39M | 22.38M | 16.83M | 10.50M | 7.14M | 4.23M |
| General & Administrative | 103.66M | 95.63M | 84.38M | 84.49M | 60.56M | 33.04M | 25.11M | 20.15M | 14.11M | 8.34M | 3.90M | 3.37M |
| Selling & Marketing | 79.27M | 68.85M | 58.61M | 49.96M | 43.95M | 29.50M | 23.14M | 18.32M | 13.30M | 10.62M | 8.60M | 7.80M |
| SG&A | 182.93M | 164.48M | 142.98M | 134.46M | 104.51M | 62.54M | 48.25M | 38.47M | 27.42M | 18.96M | 12.50M | 11.16M |
| Other Expenses | 0.00 | 94.59M | 82.79M | 76.06M | 34.70M | -1.85M | -2.23M | -1.09M | -589.00K | -374.00K | -129.00K | -147.00K |
| Operating Expenses | 401.74M | 452.44M | 383.14M | 335.33M | 216.79M | 103.52M | 80.50M | 65.14M | 46.46M | 31.10M | 21.28M | 17.03M |
| Cost & Expenses | 871.45M | 824.10M | 715.99M | 653.57M | 422.88M | 209.57M | 175.11M | 137.16M | 100.64M | 70.98M | 50.49M | 39.00M |
| Interest Income | 12.14M | 1.76M | 1.50M | 1.05M | 5.91M | 1.68M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 55.46M | 48.42M | 36.57M | 34.88M | 24.77M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 44.00K | 326.00K |
| Depreciation & Amortization | 153.08M | 161.20M | 137.19M | 115.90M | 55.35M | 18.19M | 15.95M | 13.19M | 8.60M | 1.64M | 4.27M | 3.37M |
| EBITDA | 282.42M | 171.53M | 102.97M | 154.93M | 123.28M | 94.00M | 68.14M | 54.40M | 34.74M | 22.76M | 15.79M | 10.19M |
| EBITDA Ratio | 28.25% | 23.22% | 22.71% | 27.15% | 29.21% | 33.37% | 30.66% | 30.50% | 27.40% | 20.64% | 25.26% | 22.37% |
| Operating Income | 128.13M | 38.92M | 34.64M | 83.28M | 77.01M | 77.67M | 54.42M | 41.21M | 26.14M | 16.87M | 11.52M | 7.09M |
| Operating Income Ratio | 12.82% | 4.52% | 4.58% | 11.35% | 14.48% | 27.04% | 23.71% | 23.10% | 20.62% | 19.21% | 18.58% | 15.39% |
| Total Other Income/Expenses | -53.09M | -47.15M | -42.50M | -29.87M | -33.85M | -1.85M | -2.23M | -1.09M | -589.00K | -1.11M | -6.15M | -590.00K |
| Income Before Tax | 75.04M | -38.10M | -66.74M | 4.14M | 43.16M | 75.82M | 52.19M | 40.12M | 25.55M | 15.76M | 5.37M | 6.50M |
| Income Before Tax Ratio | 7.51% | -4.42% | -8.82% | 0.56% | 8.11% | 26.40% | 22.74% | 22.49% | 20.16% | 17.94% | 8.67% | 14.11% |
| Income Tax Expense | 19.33M | -11.95M | -22.45M | -4.69M | 3.49M | 1.92M | 4.83M | 13.74M | 8.94M | 5.60M | 4.14M | -4.67M |
| Net Income | 55.71M | -26.14M | -44.29M | 8.83M | 39.66M | 73.90M | 47.36M | 26.38M | 16.61M | 10.17M | 1.23M | 11.17M |
| Net Income Ratio | 5.57% | -3.03% | -5.85% | 1.20% | 7.46% | 25.73% | 20.63% | 14.79% | 13.10% | 11.57% | 1.99% | 24.23% |
| EPS | 0.65 | -0.31 | -0.53 | 0.12 | 0.59 | 1.20 | 0.79 | 0.45 | 0.29 | 0.39 | -1.26 | 0.51 |
| EPS Diluted | 0.64 | -0.31 | -0.53 | 0.12 | 0.58 | 1.17 | 0.77 | 0.44 | 0.28 | 0.21 | -1.26 | 0.21 |
| Weighted Avg Shares Out | 85.56M | 84.44M | 83.13M | 74.24M | 67.03M | 61.84M | 60.30M | 58.62M | 56.72M | 31.18M | 5.65M | 7.76M |
| Weighted Avg Shares Out (Dil) | 86.96M | 84.44M | 83.13M | 75.68M | 68.45M | 63.37M | 61.85M | 59.89M | 58.86M | 51.86M | 5.65M | 45.85M |
HealthEquity Announces Retirement of CEO Jon Kessler; Scott Cutler Appointed Successor
HealthEquity, Inc. (HQY) Soars to 52-Week High, Time to Cash Out?
HealthEquity (HQY) Moves 9.8% Higher: Will This Strength Last?
Here's Why HealthEquity (HQY) is a Strong Growth Stock
HealthEquity Announces Third Quarter Earnings Release Date
3 Reasons Growth Investors Will Love HealthEquity (HQY)
HealthEquity receives two top honors at the 19th Annual Golden Globee® Awards for Technology
HealthEquity, Inc. (HQY) Hits Fresh High: Is There Still Room to Run?
3 Medical Services Stocks to Buy to Navigate Industry Challenges
HealthEquity Gains 28.3% YTD: What's Driving the Stock?
Source: https://incomestatements.info
Category: Stock Reports